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Another suggestion to explain the discrepancy is that some patients in the present series with mild membranous nephropathy have been included in the minimal change group. This is very unlikely in view of the clinical presentation and course of the 15 patients allocated to the minimal change group. All had highly selective differential protein clearances (Cameron and Blandford, 1966) and normal renal function. Ten of these patients subsequently lost their proteinuria, either spontaneously or as the result of therapy in the associated trial (Sharpstone et al., 1969) , and a further four showed great reduction in proteinuria with clinical improvement; only one patient failed to respond to steroids at all.
The possibility remains, however, that there may be geographical variations in the incidence of membranous nephropathy, and a number of clinicians have the impression from experience on either side of the Atlantic that the condition is commoner in the United States than in England.
Sex Incidence
Even allowing for the difficulty in assessing renal histology just discussed, the sex ratios found in this survey were surprising. In children, a group largely consisting of patients with minimal change histology, a rather constant male: female ratio of 2: 1 is found (Rothenberg and Heymann, 1957 Arneil, 1961) . Most previous series of adult nephrotics have shown either equal sex incidence or a preponderance of males (Heptinstall, 1966; , though Pearl et al. (1963) also reported an excess of females in their series, which consisted of 53 adults and children.
Renal Amyloidosis
Although the trial protocol specifically excluded patients with evidence of multi-systern disease, it is of interest that six patients (10 7% of total) fulfilling the clinical and biochemical criteria for entry were found on renal biopsy to have amyloidosis. This is in line with the incidence of 11 to 12% in other series of nephrotic patients (Berman and Schreiner, 1958; Blainey et al., 1960; Maxwell et al., 1964) and emphasizes the value of renal biopsy in the nephrotic syndrome in adults. Only one patient had a possible associated condition (mild bronchiectasis), but during the period of the survey biopsy was carried out in a further three patients with amyloidosis, rheumatoid arthritis, and the nephrotic syndrome. This is in keeping with the finding of Brandt et al. (1968) Summary: A controlled trial in 20 adult patients with the nephrotic syndrome due to proliferative glomerulonephritis compared the effects of consecutive eight-week courses of treatment with prednisolone in conventional dosage and a low-dose azathioprine-prednisolone combination. Though the azathioprine regimen avoided serious toxicity and produced a statistically significant improvement in creatinine clearance and urine protein excretion, the results were not significantly better than with prednisolone itself and overall were not of great clinical value. Prolongation of the azathioprine-predniso-*Lecturer in Medicine, King's College Hospital Medical School, London S.E.5.
Introduction
The value of corticosteroids in the treatment of adult patients with the nephrotic syndrome is small because this is largely confined to those with mild or minimal lesions of the glomeruli (Blainey et al., 1960 ; Nesson et al., 1963 ; Pearl et al., 1963; Jensen and Jensen, 1967; Cameron, 1968) . The demonstration of some benefit from the use of cytotoxic and antimetabolite drugs in some patients with corticosteroid-resistant disease (White et al., 1966 ; Adams et al., 1967 ; Michael et al., 1967 Kark and Muehrcke (1954) . Classification of the renal histology was as described in the previous paper (Sharpstone et al., 1969) , and on notification of the result of this to the referring physician the allocated treatment regimen was started. At the end of each of the three treatment periods further plasma samples and aliquots of three 24-hour urine collections were requested. Chemical estimations were carried out centrally and results obtained for 24-hour creatinine clearance, urea clearance, and protein excretion, all averaged over three days. Cameron and Blandford (1966) and expressed as the ratio urinary Cig. /C transferrin.
Results
Twenty-nine patients entered the trial; 20 had proliferative glomerulonephritis of varying degrees of severity, eight had no or minimal histological abnormality, and one had membranous nephropathy. The renal biopsy findings and initial features for the first two groups are given in Tables I and II, while N.S.
S.E. = Standard error. P based on t test applied to paired differences between before and after treatment results in each patient.
N.S. = P > 0-05.
Results at One Year
The results after a further eight months' treatment with azathioprine and prednisolone are shown in Table III . By this time two further patients (Cases 7 and 16) had lost their proteinuria. Case 19 was withdrawn from the trial at six months because of cellulitis of the legs and buccal ulceration, but her white blood count at this time was 20,000/cu. mm. and probably these complications were the result of her disease rather than the treatment.
For the remaining 11 patients the mean paired change in creatinine clearance between 16 weeks and one year was -15-9 ±10-8 ml./min. (P>0-1) and the change in proteinuria was -2-6±0 95 g./24 hours (0-05>P>0-02).
Minimal Change Histology
The urine of six of the eight patients in this group became free from protein within eight weeks of starting oft prednisolone, and in the other two cases there was a definite reduction (Table V) . These two patients subsequently received azothioprine in addition, with a decrease in proteinuria in one and an increase in the other. Case 1 subsequently lost his proteinuria on continued treatment with the two drugs, while in Case 3 heavy proteinuria persisted. Three of the remaining patients remained in remission to one year without further treatment, while the other three relapsed after stopping prednisolone and required further steroid treatment. (Doak et al., 1968; Woodruff, 1969) , and in the experimental field NZB and NZB/NZW mice have been shown to develop thymic lymphomas after the administration of azathioprine alone (Casey, 1968a (Casey, , 1968b (Rose and Black, 1967) showed that some decrease in the quantity of proteinuria was foumd in adults with proliferative glomerulonephritis, equally in those who received corticosteroids and those who did not. In this situation of the present trial, where both regimens apparently show an effect and no untreated group is included, Il __i the assumption must be made that most or all of the improvement is part of the natural history of the condition.
Though our findings suggest that azathioprine for eight weeks in the dose used may have some slight favourable influence on the course of the disease, the clinical benefit to the patients was small, most of the patients still falling within our definition of the nephrotic syndrome after treatment. Of the two " cured " patients, one had the histological picture of acute glomerulonephritis and the other a mild glomerular lesion, and in both cases the possibility of a remission occurring with steroid alone or without any treatment cannot be excluded. Investigation of a larger number of patients might improve the statistical significance of the results, but it seems likely that our original hope of producing substantial benefit in the short term with relatively non-toxic doses of azathioprine and prednisolone will not be realized.
The significance of the results of a further 36 weeks' treatment with the combined drugs is limited, since no controls were available for this period. Proteinuria was lost in two further patients and significantly reduced in the others. The mean fall in creatinine clearance during this time was not statistically significant, but possibly deteriorating renal function accounted in part for the diminished proteinuria in the latter patients. Nevertheless, these results do perhaps indicate that in future trials treatment periods of longer than eight weeks' duration should be assessed.
We cannot conclude from this study that imnmunosuppressive or cytotoxic agents are without value in nephrotics with proliferative glomerulonephritis. Proliferative glomerulonephritis may comprise a variety of different conditions. The possibility remains that the low-dose azathioprine treatment may be of value in some of the patients, such as those with mild lesions. Because of the small numbers in the present trial, further subdivision of the patients was impossible, but this question may be answered by larger collaborative trials such as that currently being sponsored by the Medical Research Council. A second possibility is that larger doses of azathioprine may be effective. Our previous experience (White et al., 1966) of the toxic effects of these higher doses renders this approach too dangerous to be useful. Finally, a third possibility is that another cytotoxic agent, such as cyclophosphamide or chlorambucil, might be effective. It is by no means certain that any of these agents act via their immunosuppressive activity, and their success in this minimal change group, where there is no evidence as yet of any immune disturbance, supports this suggestion. At present we are investigating the value of cyclophosphamide and chlorambucil in the group of patients discussed in this paper.
Minimal Change Lesion
Corticosteroid therapy alone produces remission of proteir.-uria in most children with the nephrotic syndrome and normal or minimal change renal histology (White, 1967; Cameron, 1968) , and similar results have been obtained in the smaller number of adults investigated (Blainey et al., 1960; Nesson et al., 1963 Pearl et al., 1963 Jensen and Jensen, 1967; Cameron, 1968) . Our results confirm that the overall poorer response to corticosteroid therapy of the nephrotic syndrome in adults is due to the higher proportion of patients with severe glomerular disease in this age group rather than to any difference in the response to corticosteroids between adults and children who have minimal lesions.
The main problems in the management of these patients are the groups who require unacceptably high doses of steroid for control (steroid resistant) or who relapse frequently between course of treatment (steroid dependent). Cytotoxic drugs have been strikingly successful in children in this situation (White, 1967; Lagrue et al., 1967; Moncrieff st al., 1969; Soothill of al., 1969) . In most instances cyclophosphamide or chlorambucil was used. In adults little information is available for any cytotoxic agent in this group. Whereas Adams et al. (1967) produced remission in the two patients they treated with azathioprine and prednisolone, Michael et al. (1967) had a favourable response in only one out of three such patients. In the two patients in the present trial who failed to lose proteinuria on prednisolone the addition of azathioprine for eight weeks was associated with a reduction in proteinuria in one and an increase in the other.
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